Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / VBLT - VBL's VB-111 shows positive effect in late-stage ovarian cancer study

VBLT - VBL's VB-111 shows positive effect in late-stage ovarian cancer study

Vascular Biogenics Ltd.
  • VBL Therapeutics (NASDAQ:VBLT) announces positive interim results from a Phase 3 clinical trial, OVAL, evaluating VB-111 in patients with platinum-resistant ovarian cancer.
  • More news on: Vascular Biogenics Ltd., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Vascular Biogenics Ltd.
Stock Symbol: VBLT
Market: NASDAQ
Menu
VBLT VBLT Quote VBLT Short VBLT News VBLT Articles VBLT Message Board
Get VBLT Alerts

News, Short Squeeze, Breakout and More Instantly...